Tag: COLD CHAIN

Sinopharm Suits Zimbabwe’s Cold Chain Capacity

Michael Gwarisa

UNLIKE other COVID-19 vaccines that were developed using  the Messenger Ribonucleic Acids (M-RNA) technology, vaccines manufactured using a killed/inactivated virus such as the Sinopharm, Sinovac and COVAXIN currently being administered in Zimbabwe do not require expensive subzero cold-chain infrastructure. By Michael Gwarisa The messenger RNA technology was deployed in the Pfizer, Mordena and other vaccines, making such vaccines unsuitable for hot climatic conditions such as the one in Zimbabwean unless the country installs a costly deep freeze airport warehouse, procures and modifies refrigerated vehicles and inoculation points to ensure the…

Read More

First Batch Of Sinopharm Vaccine To Be distributed In Zim Immediately After Arrival Next Week

Michael Gwarisa

ZIMBABWE will on Monday, February 15, 2021 receive a donation of the Sinopharm Vaccine from the Republic of China which is set to be distributed immediately after arrival according to a top government official. By Michael Gwarisa Zimbabwe has purchased 600 000 on top of the 200 000 Sinopharm vaccine doses which were donated by the Government of China. The Sinopharm vaccine has efficacy rates ranging from 76 to 86% and has already been used by other countries in controlling COVID-19. Speaking during a televised briefing on the COVID-19 Vaccine…

Read More